PubRank

E A Mayer

Author PubWeight™ 130.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995 3.95
2 Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000 3.71
3 The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000 3.25
4 A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med 2001 3.05
5 Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 1997 2.77
6 Cyclic vomiting syndrome in adults. Neurogastroenterol Motil 2008 2.40
7 Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology 1994 2.39
8 Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology 1997 2.39
9 Effect of hypnotherapy and educational intervention on brain response to visceral stimulus in the irritable bowel syndrome. Aliment Pharmacol Ther 2013 2.26
10 Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am J Physiol Gastrointest Liver Physiol 2002 2.10
11 Stimulus and site specific induction of hiccups in the oesophagus of normal subjects. Gut 1997 2.10
12 Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 2007 1.98
13 Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain 2000 1.97
14 Sleep disturbances in clinic patients with functional bowel disorders. Am J Gastroenterol 2000 1.96
15 Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology 1997 1.94
16 The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther 2004 1.76
17 Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998 1.70
18 Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther 1999 1.66
19 Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med 2001 1.64
20 Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain. Neurogastroenterol Motil 2009 1.58
21 Estradiol inhibits atp-induced intracellular calcium concentration increase in dorsal root ganglia neurons. Neuroscience 2003 1.53
22 Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 1999 1.49
23 Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998 1.48
24 Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention. Aliment Pharmacol Ther 2012 1.47
25 Gender-related differences in IBS symptoms. Am J Gastroenterol 2001 1.47
26 Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: a network analysis. Neuroimage 2008 1.43
27 CRF2 receptor activation prevents colorectal distension induced visceral pain and spinal ERK1/2 phosphorylation in rats. Gut 2005 1.41
28 Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil 2008 1.41
29 Sensation of bloating and visible abdominal distension in patients with irritable bowel syndrome. Am J Gastroenterol 2001 1.40
30 Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients. Am J Gastroenterol 2000 1.38
31 Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998 1.37
32 Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut 2005 1.37
33 Rectal afferent function in patients with inflammatory and functional intestinal disorders. Pain 1996 1.35
34 An irritable bowel syndrome-specific symptom questionnaire: development and validation. Scand J Gastroenterol 2003 1.34
35 Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil 2009 1.32
36 Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology 2001 1.28
37 Gender differences in regional brain response to visceral pressure in IBS patients. Eur J Pain 2000 1.23
38 Neurokinin 1 receptor internalization in spinal cord slices induced by dorsal root stimulation is mediated by NMDA receptors. J Neurosci 1997 1.21
39 Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am J Gastroenterol 1999 1.19
40 Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism. Br J Pharmacol 2001 1.18
41 Audio and visual stimulation reduces patient discomfort during screening flexible sigmoidoscopy. Am J Gastroenterol 1998 1.17
42 Long-term evaluation of pylorus preservation during pancreaticoduodenectomy. World J Surg 1988 1.17
43 Perceptual responses in patients with inflammatory and functional bowel disease. Gut 2000 1.13
44 Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials. Aliment Pharmacol Ther 2001 1.13
45 Symptoms and physiology in severe chronic constipation. Am J Gastroenterol 1999 1.11
46 Differential effects of chemical and mechanical colonic irritation on behavioral pain response to intraperitoneal acetic acid in mice. Pain 1999 1.09
47 Subtypes of constipation predominant irritable bowel syndrome based on rectal perception. Gut 1998 1.08
48 Gastric processing and emptying of fat. Gastroenterology 1986 1.04
49 The effect of octreotide on human gastric compliance and sensory perception. Neurogastroenterol Motil 1995 1.00
50 Sleep and duodenal motor activity in patients with severe non-ulcer dyspepsia. Gut 1994 0.98
51 Substance P release in the dorsal horn assessed by receptor internalization: NMDA receptors counteract a tonic inhibition by GABA(B) receptors. Eur J Neurosci 1999 0.98
52 Sexual dysfunction in patients with irritable bowel syndrome and non-ulcer dyspepsia. Digestion 1998 0.97
53 Internalization of mu-opioid receptors in rat spinal cord slices. Neuroreport 1999 0.95
54 Involvement of spinal calcitonin gene-related peptide in the development of acute visceral hyperalgesia in the rat. Neurogastroenterol Motil 2001 0.94
55 Irritable bowel syndrome patients show altered sensitivity to exogenous opioids. Pain 2000 0.94
56 Calcium waves in colonic myocytes produced by mechanical and receptor-mediated stimulation. Am J Physiol 1999 0.93
57 Autonomic response to a visceral stressor is dysregulated in irritable bowel syndrome and correlates with duration of disease. Neurogastroenterol Motil 2013 0.93
58 Acute tryptophan depletion alters the effective connectivity of emotional arousal circuitry during visceral stimuli in healthy women. Gut 2011 0.93
59 Sensational developments in the irritable bowel. Gut 1996 0.92
60 Gastroenterologic causes of chronic pelvic pain. Obstet Gynecol Clin North Am 1993 0.92
61 Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study. Aliment Pharmacol Ther 2008 0.91
62 Propagation of calcium waves between colonic smooth muscle cells in culture. Cell Calcium 1996 0.91
63 Sigmoid afferent mechanisms in patients with irritable bowel syndrome. Dig Dis Sci 1997 0.91
64 Consensus statement on depression, anxiety, and functional gastrointestinal disorders. J Clin Psychiatry 2001 0.91
65 Sex-dependent differences in the activity and modulation of N-methyl-d-aspartic acid receptors in rat dorsal root ganglia neurons. Neuroscience 2007 0.90
66 Anti-hyperalgesic effect of octreotide in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2004 0.89
67 Subdiaphragmatic vagal afferent innervation in activation of an opioidergic antinociceptive system in response to colorectal distension in rats. Neurogastroenterol Motil 2002 0.88
68 Mechanical activation of dorsal root ganglion cells in vitro: comparison with capsaicin and modulation by kappa-opioids. Brain Res 2000 0.88
69 Selective knockdown of NMDA receptors in primary afferent neurons decreases pain during phase 2 of the formalin test. Neuroscience 2010 0.88
70 Traditional Chinese medicine based subgrouping of irritable bowel syndrome patients. Am J Chin Med 2005 0.88
71 Duodenal fat intensifies the perception of heartburn. Gut 2001 0.87
72 Gastric emptying and sieving of solid food and pancreatic and biliary secretion after solid meals in patients with truncal vagotomy and antrectomy. Gastroenterology 1982 0.87
73 Sex-related differences in prepulse inhibition of startle in irritable bowel syndrome (IBS). Biol Psychol 2010 0.86
74 N-methyl-D-aspartate receptors enhance mechanical responses and voltage-dependent Ca2+ channels in rat dorsal root ganglia neurons through protein kinase C. Neuroscience 2004 0.86
75 Temporal relationships of cholecystokinin release, pancreatobiliary secretion, and gastric emptying of a mixed meal. Gastroenterology 1988 0.85
76 Familial visceral neuropathy with autosomal dominant transmission. Gastroenterology 1986 0.85
77 Reassessment of gastric acid inhibition by cholecystokinin and gastric inhibitory polypeptide in dogs. Gastroenterology 1982 0.84
78 Involvement of substance P in noncholinergic excitation of rabbit colonic muscle. Am J Physiol 1989 0.84
79 Impact of advertisement and clinic populations in symptoms and perception of irritable bowel syndrome. Aliment Pharmacol Ther 1999 0.84
80 Characterization of afferent mechanisms in ileoanal pouches. Am J Gastroenterol 1997 0.83
81 Toward a biobehavioral model of visceral hypersensitivity in irritable bowel syndrome. J Psychosom Res 1998 0.83
82 Towards an integrative model of irritable bowel syndrome. Prog Brain Res 2000 0.83
83 A combined nutrient and lactulose challenge test allows symptom-based clustering of patients with irritable bowel syndrome. Am J Gastroenterol 2013 0.82
84 Characterization of bombesin effects on canine gastric muscle. Am J Physiol 1982 0.82
85 Chemical signaling from colonic smooth muscle cells to DRG neurons in culture. Am J Physiol 1999 0.82
86 Psychosocial moderators of quality of life in irritable bowel syndrome. Eur J Surg Suppl 1998 0.82
87 Symptom duration in patients with irritable bowel syndrome. Am J Gastroenterol 1996 0.82
88 Involvement of stretch-sensitive calcium flux in mechanical transduction in visceral afferents. J Auton Nerv Syst 1999 0.81
89 Nitric oxide synthase inhibitors enhance mechanosensitive Ca(2+) influx in cultured dorsal root ganglion neurons. Brain Res 2001 0.81
90 Differences in brain responses between lean and obese women to a sweetened drink. Neurogastroenterol Motil 2013 0.81
91 Gastric emptying and sieving of solid food and pancreatic and biliary secretions after solid meals in patients with nonresective ulcer surgery. Gastroenterology 1984 0.80
92 Neuroimaging placebo effects: new tools generate new questions. Clin Pharmacol Ther 2009 0.80
93 Measurement of symptoms in irritable bowel syndrome clinical trials. Am J Med 1999 0.79
94 Neurokinin 3 receptors in the gut: a new target for the treatment of visceral pain? Gastroenterology 1999 0.79
95 Intercellular communication between dorsal root ganglion cells and colonic smooth muscle cells in vitro. Neuroreport 1997 0.78
96 Differences in the response of proximal and distal rabbit colonic muscle after electrical field stimulation. Gastroenterology 1989 0.78
97 Gastrointestinal sensory abnormalities in functional dyspepsia. Baillieres Clin Gastroenterol 1998 0.78
98 The pathophysiology of irritable bowel syndrome. Minerva Med 2004 0.78
99 Substance P induces brief, localized increase in [Ca2+]i in dorsal horn neurons. Neuroreport 1998 0.77
100 Cerebral activation in irritable bowel syndrome. Gastroenterology 2000 0.77
101 Characterization of substance P effects on canine antral muscle. Am J Physiol 1986 0.77
102 Characterization of the effects of neurokinins on canine antral muscle. Am J Physiol 1988 0.77
103 Mechanotransduction in colonic smooth muscle cells. J Membr Biol 1997 0.77
104 Calcium dependence of neurotensin stimulation of circular colonic muscle of the rabbit. Gastroenterology 1987 0.76
105 Involvement of chloride channels in the receptormediated activation of longitudinal colonic muscle. Neurogastroenterol Motil 1998 0.76
106 Reversal of megaduodenum and duodenal dysmotility associated with improvement in nutritional status in primary anorexia nervosa. Dig Dis Sci 1994 0.76
107 VIP modulates intracellular calcium oscillations in human lymphoblasts. Immunopharmacol Immunotoxicol 1993 0.76
108 Gut feelings: what turns them on? Gastroenterology 1995 0.75
109 Evolving concepts in irritable bowel syndrome. Curr Opin Gastroenterol 1999 0.75
110 [Epidemiology and clinical phenomenology of visceral pain]. Schmerz 2002 0.75
111 GIP and insulin release in relation to gastric emptying of a mixed meal in man. Regul Pept 1989 0.75
112 Somatostatin modulates cholinergic neurotransmission in canine antral muscle. Am J Physiol 1988 0.75
113 Potency of natural and synthetic canine gastrin-releasing decapeptide on canine antral muscle. Am J Physiol 1986 0.75
114 [Sensory function and functional diseases of the gastrointestinal system]. Dtsch Med Wochenschr 2001 0.75
115 Common functional gastrointestinal disorders: nonulcer dyspepsia and irritable bowel syndrome. Clin Cornerstone 1999 0.75